Breast cancer is the most common cancer affecting women worldwide. It is a malignant and
heterogeneous disease with distinct molecular subtypes, which has prognostic and …

Release of cell free DNA (cfDNA) from damaged or dead cells routinely occurs in normal
physiology. Recently, cfDNA has emerged as an essential biomarker in cardiovascular …

Breast cancer is the most prevalent and leading cause of mortality worldwide among
women. Cell-free DNA (cfDNA) analysis is an alternative quantitative approach to …

Simple yet powerful clustered regularly-interspaced short palindromic repeats (CRISPR)
technology has led to the advent of numerous developments in life sciences, biotechnology …

While tissue biopsy has for the longest time been the gold-standard in biomedicine,
precision/personalized medicine is making the shift toward liquid biopsies. Cell-free DNA …

Among women, breast cancer (BC) is not only the most common cancer worldwide but also
the leading cause of cancer death. Only 5–10% of breast cancer cases are attributed to …

Next-generation sequencing has enabled patient selection for targeted drugs, some of
which have shown remarkable efficacy in cancers that have the cognate molecular …

Abstract Analysis of circulating cell-free DNA (ccfDNA) is a suitable tool for detecting somatic
mutations for the purpose of making decisions on treatment, monitoring treatment response …

Simple Summary Our research focuses in the elucidation of the nature of circulating cell-free
DNA (ccfDNA) as a biological entity and its exploitation as a liquid biopsy biomaterial …

Advances in genomic strategies and the development of targeted therapies have enabled
precision medicine to revolutionise the field of oncology. Precision medicine uses patient …